| This article has been cited by |
| 1 | Safety and Tolerability Profile of Second-Line Anti-Tuberculosis Medications | |
| Geetha Ramachandran,Soumya Swaminathan |
| Drug Safety.2015;38(3)253 |
| [DOI] |
|
| 2 | The combined fixed-dose antituberculous drugs alter some reproductive functions with oxidative stress involvement in wistar rats | |
| O. Awodele,A.A. Momoh,N.A. Awolola,O.E. Kale,W.O. Okunowo |
| Toxicology Reports.2016;3(3)620 |
| [DOI] |
|
| 3 | Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide | |
| Hai-Nan Zhang,Zhao-Wei Xu,He-Wei Jiang,Fan-Lin Wu,Xiang He,Yin Liu,Shu-Juan Guo,Yang Li,Li-Jun Bi,Jiao-Yu Deng,Xian-En Zhang,Sheng-Ce Tao |
| Scientific Reports.2017;7(1)620 |
| [DOI] |
|
| 4 | Ethionamide-induced gynecomastia: A rare case report | |
| Sourindra N. Banerjee,Rupam K. Ta,Md. Salim Mallick,Manish K. Munda |
| Egyptian Journal of Bronchology.2017;11(1)70 |
| [DOI] |
|
| 5 | Breast tuberculosis in men: A systematic review | |
| GianLuca Quaglio,Damiano Pizzol,Anna Bortolani,Fabio Manenti,Petros Isaakidis,Giovanni Putoto,Piero L. Olliaro,Iratxe Puebla |
| PLOS ONE.2018;13(4)e0194766 |
| [DOI] |
|
| 6 | A review of the use of ethionamide and prothionamide in childhood tuberculosis | |
| S. Thee,A.J. Garcia-Prats,P.R. Donald,A.C. Hesseling,H.S. Schaaf |
| Tuberculosis.2016;97(4)126 |
| [DOI] |
|
| 7 | MDR Tuberculosis Treatment | |
| Juan Espinosa-Pereiro,Adrian Sánchez-Montalvá,Maria Luisa Aznar,Maria Espiau |
| Medicina.2022;58(2)188 |
| [DOI] |
|
| 8 | Carrageenan-stabilized chitosan alginate nanoparticles loaded with ethionamide for the treatment of tuberculosis | |
| Sharif Abdelghany,Maha Alkhawaldeh,Hatim S. AlKhatib |
| Journal of Drug Delivery Science and Technology.2017;39(2)442 |
| [DOI] |
|
| 9 | Carrageenan-stabilized chitosan alginate nanoparticles loaded with ethionamide for the treatment of tuberculosis | |
| Bernard Naafs,Colette L. M. van Hees,Jakko van Ingen |
| Journal of Drug Delivery Science and Technology.2016;39(2)81 |
| [DOI] |
|
